Hark Capital Provides $50 Million NAV Facility To Pharos Capital Group
“We are thrilled to build on our long-standing relationship with Pharos Capital Group and support their mission of investing in high-impact healthcare companies,” said Rafael Castro, Partner at Hark Capital.“The transaction marks the third financing facility between our two firms and underscores Hark's commitment to supporting enduring middle-market franchises.”
Joel Goldberg, Partner of Pharos Capital Group added,“We value Hark Capital's partnership and their ability to deliver flexible financing solutions that align with our strategy of building healthcare companies that expand access and improve outcomes.”
The financing leverages the credit strength and diversification of the Pharos IV-A portfolio to strategically obtain attractive and flexible capital. The transaction highlights Hark Capital's leadership in the NAV lending space and its continued focus on delivering innovative fund finance solutions to middle-market sponsors.
About Hark Capital
Since 2013, Hark Capital, a subsidiary of P10, Inc. (NYSE: PX), has been a pioneer in providing creative, non-dilutive fund finance solutions for middle-market private equity sponsors, with a focus on NAV-based and management company facilities. Since inception, Hark Capital has deployed over $1.7 billion across 130+ transactions with more than 60 sponsors in the US, Canada and Europe.
Hark Capital Advisors, LLC
Email: ...
About Pharos Capital Group
Based in Dallas and Nashville, Pharos Capital Group is a physician-founded investment firm focused on growing healthcare companies that aim to lower the total cost of care, improve patient outcomes and expand access to care in underserved markets. Since inception, Pharos has invested in 61 companies and has over $900 million of private equity assets under management as of June 30, 2025. Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations, predominantly across healthcare sectors. For more information on Pharos, please visit or visit us on LinkedIn at .


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Buy Now Pay Later Market Size To Surpass USD 145.5 Billion By 2033 CAGR Of 22.23%
- BTCC Summer Festival 2025 Unites Japan's Web3 Community
- GCL Subsidiary, 2Game Digital, Partners With Kucoin Pay To Accept Secure Crypto Payments In Real Time
- Smart Indoor Gardens Market Growth: Size, Trends, And Forecast 20252033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- Pluscapital Advisor Empowers Traders To Master Global Markets Around The Clock
Comments
No comment